Regulation of human metabolism by hypoxia-inducible factor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 28, 2010, Pages 12722-12727

  Formenti, Federico ^a   Constantin Teodosiu, Dumitru ^b   Emmanuel, Yaso ^a   Cheeseman, Jane ^c   Dorrington, Keith L ^a   Edwards, Lindsay M ^a   Humphreys, Sandy M ^c   Lappin, Terence R J ^d   McMullin, Mary F ^d   McNamara, Christopher J ^e   Mills, Wendy ^f   Murphy, John A ^g   O'Connor, David F ^a   Percy, Melanie J ^d   Ratcliffe, Peter J ^h   Smith, Thomas G ^a   Treacy, Marilyn ⁱ   Frayn, Keith N ^c   Greenhaff, Paul L ^b   Karpe, Fredrik ^c,j   Clarke, Kieran ^a   Robbins, Peter A ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

^g MONKLANDS HOSPITAL   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^j NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

more..

Author keywords

Chuvash polycythemia; Exercise; Glycolysis; Lactate; Von Hippel Lindau

Indexed keywords

6 PHOSPHOFRUCTOKINASE; HEXOKINASE 1; HEXOKINASE 2; HYPOXIA INDUCIBLE FACTOR; LACTATE DEHYDROGENASE; LACTIC ACID; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 4; PYRUVATE KINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BICYCLE ERGOMETRY; CELL METABOLISM; CHUVASH POLYCYTHEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; MALE; METABOLIC REGULATION; METABOLIC STRESS; MUSCLE MASS; MUSCLE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POLYCYTHEMIA; PRIORITY JOURNAL;

ADULT; ANOXIA; EXERCISE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LACTATES; LACTIC ACID; MALE; MUSCLE, SKELETAL; MUSCLES; OXYGEN; POLYCYTHEMIA; TRANSCRIPTION FACTORS;

EID: 77955456405     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1002339107     Document Type: Article

References (54)

1. Wang GL, Semenza GL (1995) Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270:1230-1237.
2. Salceda S, Caro J (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem 272:22642-22647.
3. Jaakkola P, et al. (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468-472.
4. Ivan M, et al. (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science 292:464-468.
5. Epstein AC, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
6. Maxwell PH, et al. (1999) The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
7. Ohh M, et al. (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2:423-427.
8. Semenza GL (2007) Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 405:1-9. (Pubitemid 46999919)
9. Semenza GL (2004) Hydroxylation of HIF-1: Oxygen sensing at the molecular level. Physiology (Bethesda) 19:176-182.
10. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343-354.
11. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ (1994) Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3́ enhancer. Proc Natl Acad Sci USA 91:6496-6500. (Pubitemid 24984963)
12. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187-197.
13. Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177-185. (Pubitemid 43316523)
14. Aragonés J, et al. (2008) Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40:170-180.
15. Fukuda R, et al. (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129:111-122. (Pubitemid 46507584)
16. Zhang H, et al. (2008) Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 283:10892-10903.
17. Sergeyeva A, et al. (1997) Congenital polycythemia in Chuvashia. Blood 89:2148-2154.
18. Bushuev VI, et al. (2006) Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 91:744-749.
19. Ang SO, et al. (2002) Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 32:614-621.
20. Smith TG, et al. (2006) Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 3:e290.
21. Weibel ER, Hoppeler H (2005) Exercise-induced maximal metabolic rate scales with muscle aerobic capacity. J Exp Biol 208:1635-1644.
22. Greenhaff PL, et al. (2002) An acetyl group deficit limits mitochondrial ATP production at the onset of exercise. Biochem Soc Trans 30:275-280.
23. Greenhaff PL, et al. (2004) Metabolic inertia in contracting skeletal muscle: A novel approach for pharmacological intervention in peripheral vascular disease. Br J Clin Pharmacol 57:237-243.
24. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, Popov KM (1998) Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329:191-196.
25. Gudi R, Bowker-Kinley MM, Kedishvili NY, Zhao Y, Popov KM (1995) Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem 270:28989-28994.
26. Mason SD, et al. (2007) HIF-1alpha in endurance training: Suppression of oxidative metabolism. Am J Physiol Regul Integr Comp Physiol 293:R2059-R2069.
27. Hickey MM, Lam JC, Bezman NA, Rathmell WK, Simon MC (2007) von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. J Clin Invest 117:3879-3889.
28. Hickey MM, et al. (2010) The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. J Clin Invest 120:827-839.
29. Ptashne KA, Theodore J, Robin ED (1983) Increased phosphofructokinase content during chronic hypoxia in cultured skeletal muscle (L8) cells. Biochim Biophys Acta 763:169-174. (Pubitemid 13012208)
30. Semenza GL, Roth PH, Fang HM, Wang GL (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757-23763.
31. Weibel ER, Bacigalupe LD, Schmitt B, Hoppeler H (2004) Allometric scaling of maximal metabolic rate in mammals: Muscle aerobic capacity as determinant factor. Respir Physiol Neurobiol 140:115-132.
32. Mason SD, et al. (2004) Loss of skeletal muscle HIF-1alpha results in altered exercise endurance. PLoS Biol 2:e288.
33. Coppack SW, Frayn KN, Humphreys SM, Whyte PL, Hockaday TD (1990) Arteriovenous differences across human adipose and forearm tissues after overnight fast. Metabolism 39:384-390.
34. Jansson PA, Smith U, Lönnroth P (1990) Evidence for lactate production by human adipose tissue in vivo. Diabetologia 33:253-256. (Pubitemid 20136244)
35. Kreisberg RA (1972) Glucose-lactate inter-relations in man. N Engl J Med 287:132-137.
36. Rowell LB, et al. (1966) Splanchnic removal of lactate and pyruvate during prolonged exercise in man. J Appl Physiol 21:1773-1783.
37. Cantley J, et al. (2009) Deletion of the von Hippel-Lindau gene in pancreatic beta cells impairs glucose homeostasis in mice. J Clin Invest 119:125-135.
38. Puri S, Cano DA, Hebrok M (2009) A role for von Hippel-Lindau protein in pancreatic beta-cell function. Diabetes 58:433-441.
39. Zehetner J, et al. (2008) PVHL is a regulator of glucose metabolism and insulin secretion in pancreatic beta cells. Genes Dev 22:3135-3146.
40. Hochachka PW (1988) The lactate paradox: Analysis of underlying mechanisms. Annals of Sports Medicine 4:184-188.
41. West JB (1986) Lactate during exercise at extreme altitude. Fed Proc 45:2953-2957.
42. Reeves JT, et al. (1992) Oxygen transport during exercise at altitude and the lactate paradox: Lessons from Operation Everest II and Pikes Peak. Exerc Sport Sci Rev 20:275-296.
43. West JB (2007) Point: The lactate paradox does/does not occur during exercise at high altitude. J Appl Physiol 102:2398-2399.
44. Dempsey JA, et al. (1972) Control of exercise hyperpnea under varying durations of exposure to moderate hypoxia. Respir Physiol 16:213-231.
45. Klausen K, Robinson S, Micahel ED, Myhre LG (1966) Effect of high altitude on maximal working capacity. J Appl Physiol 21:1191-1194.
46. Brooks GA (2007) Comments on Point:Counterpoint: "The lactate paradox does/does not occur during exercise at high altitude". J Appl Physiol, 102:2408, author reply 2409-2410.
47. Mazzeo RS (2007) Comments on Point:Counterpoint: "The lactate paradox does/does not occur during exercise at high altitude". J Appl Physiol, 102:2403, author reply 2409-2410.
48. van Hall G (2007) Counterpoint: The lactate paradox does not occur during exercise at high altitude. J Appl Physiol 102:2399-2401.
49. van Hall G, et al. (2009) The lactate paradox revisited in lowlanders during acclimatization to 4100 m and in high-altitude natives. J Physiol 587:1117-1129.
50. Hochachka PW, et al. (2002) The lactate paradox in human high-altitude physiological performance. News Physiol Sci 17:122-126.
51. Gore CJ, Clark SA, Saunders PU (2007) Nonhematological mechanisms of improved sea-level performance after hypoxic exposure. Med Sci Sports Exerc 39:1600-1609.
52. Pollard PJ, et al. (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231-2239.
53. Zhao S, et al. (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261-265.
54. Percy MJ, et al. (2003) Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. Blood 102:1097-1099.